A pioneering approach is offering researchers new insights into why some prostate cancers are more aggressive and difficult to treat. In a new application to prostate cancer research, Vancouver Coastal… Read More
Migraine is a complex neurological disorder affecting millions of people worldwide. While visual and auditory sensitivities are well-recognized symptoms, olfactory sensitivity—particularly an intolerance to strong smells—has gained increasing attention. Many… Read More
The first monoclonal antibody in Canada indicated for the treatment of adult patients with polymyalgia rheumatica (PMR) Nearly tripled the remission rates (28.3% vs 10.3%) compared to placebo in adult… Read More
EMRELIS is the first and only treatment approved for previously treated advanced NSCLC patients with high c-Met protein overexpression who often face poor prognosis and have limited treatment options Lung… Read More
AbCellera anticipates starting the Phase 1 clinical trial for ABCL635 in Q3 2025 VANCOUVER, BC – AbCellera (Nasdaq: ABCL) announced it has received a No Objection Letter (NOL) from Health… Read More
